Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
Moodys
McKesson
AstraZeneca

Last Updated: May 19, 2022

CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Calcium Gluconate In Sodium Chloride, and when can generic versions of Calcium Gluconate In Sodium Chloride launch?

Calcium Gluconate In Sodium Chloride is a drug marketed by Fresenius Kabi Usa and Hq Spclt Pharma and is included in two NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride

A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Try it Free

Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Drug patent expirations by year for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Michael Patrick AchiamPhase 1
Ahmed SaadPhase 1/Phase 2
Hawaa Fertility CenterPhase 1/Phase 2

See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials

Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE

US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE

CALCIUM GLUCONATE IN SODIUM CHLORIDE is protected by two US patents.

Patents protecting CALCIUM GLUCONATE IN SODIUM CHLORIDE

Calcium gluconate solutions in flexible containers
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Calcium gluconate solutions in flexible containers
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-004 Jun 17, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-005 Jun 17, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-003 Jun 4, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKinsey
Johnson and Johnson
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.